These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9922304

  • 1. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.
    Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, Sturrock RD, Russell RI.
    Gastroenterology; 1999 Feb; 116(2):254-8. PubMed ID: 9922304
    [Abstract] [Full Text] [Related]

  • 2. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI.
    N Engl J Med; 1996 May 30; 334(22):1435-9. PubMed ID: 8618582
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.
    Kobata Y, Yajima H, Yamao J, Tanaka Y, Fukui H, Takakura Y.
    Mod Rheumatol; 2009 May 30; 19(6):629-36. PubMed ID: 19728013
    [Abstract] [Full Text] [Related]

  • 4. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I.
    Gut; 1996 Jul 30; 39(1):22-6. PubMed ID: 8881802
    [Abstract] [Full Text] [Related]

  • 5. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY.
    Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000
    [Abstract] [Full Text] [Related]

  • 6. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I, Masaryk P, Mateicka F, Kopecký S, Rovenský J.
    Int J Clin Pharmacol Res; 2001 Jan 08; 21(3-4):119-25. PubMed ID: 12067141
    [Abstract] [Full Text] [Related]

  • 7. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
    Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Hui Y, Chan HL, Chan CS, Hui E, Woo J, Sung JJ.
    Lancet; 2002 Jan 05; 359(9300):9-13. PubMed ID: 11809180
    [Abstract] [Full Text] [Related]

  • 8. Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis.
    Yajima H, Yamao J, Fukui H, Takakura Y.
    J Orthop Sci; 2007 Jul 05; 12(4):341-6. PubMed ID: 17657553
    [Abstract] [Full Text] [Related]

  • 9. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS, McCloskey C, Prasad R, Bezlyak V.
    Lancet; 2009 Jul 11; 374(9684):119-25. PubMed ID: 19577798
    [Abstract] [Full Text] [Related]

  • 10. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.
    Hudson N, Taha AS, Russell RI, Trye P, Cottrell J, Mann SG, Swanell AJ, Sturrock RD, Hawkey CJ.
    Gastroenterology; 1997 Jun 11; 112(6):1817-22. PubMed ID: 9178671
    [Abstract] [Full Text] [Related]

  • 11. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T, Konturek PC, Sliwowski Z, Kwiecień S, Drozdowicz D, Pawlik M, Mach K, Konturek SJ, Pawlik WW.
    J Physiol Pharmacol; 2006 Sep 11; 57 Suppl 3():67-79. PubMed ID: 17033106
    [Abstract] [Full Text] [Related]

  • 12. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, Nishigaki H, Tatsuguchi A, Futagami S, Wada K, Tsukui T, Nakajima A, Yoshino S, Sakamoto C.
    Aliment Pharmacol Ther; 2005 Jun 11; 21 Suppl 2():67-72. PubMed ID: 15943850
    [Abstract] [Full Text] [Related]

  • 13. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer.
    Voutilainen M, Sokka T, Juhola M, Farkkilä M, Hannonen P.
    Scand J Gastroenterol; 1998 Aug 11; 33(8):811-6. PubMed ID: 9754727
    [Abstract] [Full Text] [Related]

  • 14. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.
    ten Wolde S, Dijkmans BA, Janssen M, Hermans J, Lamers CB.
    Aliment Pharmacol Ther; 1996 Jun 11; 10(3):347-51. PubMed ID: 8791962
    [Abstract] [Full Text] [Related]

  • 15. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT, Steen KS, Lems WF, Bijlsma JW, van de Laar MA, Huisman AM, Vonkeman HE, Houben HH, Kadir SW, Kostense PJ, van Tulder MW, Kuipers EJ, Boers M, Dijkmans BA.
    Helicobacter; 2007 Oct 11; 12(5):477-85. PubMed ID: 17760715
    [Abstract] [Full Text] [Related]

  • 16. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep 11; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 17. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J, Blum AL, Bolten WW, Dragosics B, Rösch W, Stolte M, Koelz HR.
    Gut; 2002 Sep 11; 51(3):329-35. PubMed ID: 12171952
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
    Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K.
    Gastroenterology; 1999 Jun 11; 116(6):1305-9. PubMed ID: 10348813
    [Abstract] [Full Text] [Related]

  • 19. What do we do about Helicobacter pylori?
    Hawkey CJ.
    Can J Gastroenterol; 1999 Mar 11; 13(2):143-5. PubMed ID: 10203433
    [Abstract] [Full Text] [Related]

  • 20. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori.
    Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR.
    Gastroenterology; 1992 Jun 11; 102(6):1899-905. PubMed ID: 1587409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.